Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements.

Agger EM, Rosenkrands I, Hansen J, Brahimi K, Vandahl BS, Aagaard C, Werninghaus K, Kirschning C, Lang R, Christensen D, Theisen M, Follmann F, Andersen P.

PLoS One. 2008 Sep 8;3(9):e3116. doi: 10.1371/journal.pone.0003116.

2.

Mycobacterium abscessus activates the macrophage innate immune response via a physical and functional interaction between TLR2 and dectin-1.

Shin DM, Yang CS, Yuk JM, Lee JY, Kim KH, Shin SJ, Takahara K, Lee SJ, Jo EK.

Cell Microbiol. 2008 Aug;10(8):1608-21. doi: 10.1111/j.1462-5822.2008.01151.x. Epub 2008 Mar 26.

PMID:
18373632
3.

Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus.

Kwissa M, Amara RR, Robinson HL, Moss B, Alkan S, Jabbar A, Villinger F, Pulendran B.

J Exp Med. 2007 Oct 29;204(11):2733-46. Epub 2007 Oct 22.

4.

Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells.

Rothfuchs AG, Bafica A, Feng CG, Egen JG, Williams DL, Brown GD, Sher A.

J Immunol. 2007 Sep 15;179(6):3463-71.

5.

Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity.

Heit A, Schmitz F, Haas T, Busch DH, Wagner H.

Eur J Immunol. 2007 Aug;37(8):2063-74.

6.

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC.

Science. 2007 Jun 15;316(5831):1628-32.

7.

The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors.

Hara H, Ishihara C, Takeuchi A, Imanishi T, Xue L, Morris SW, Inui M, Takai T, Shibuya A, Saijo S, Iwakura Y, Ohno N, Koseki H, Yoshida H, Penninger JM, Saito T.

Nat Immunol. 2007 Jun;8(6):619-29. Epub 2007 May 7.

PMID:
17486093
8.

Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17.

LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, Reis e Sousa C.

Nat Immunol. 2007 Jun;8(6):630-8. Epub 2007 Apr 22.

PMID:
17450144
9.

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.

Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L, Randall TD, Cooper AM.

Nat Immunol. 2007 Apr;8(4):369-77. Epub 2007 Mar 11.

PMID:
17351619
10.

The many faces of ITAMs.

Underhill DM, Goodridge HS.

Trends Immunol. 2007 Feb;28(2):66-73. Epub 2007 Jan 2. Review.

PMID:
17197236
11.

Dectin-1 is required for beta-glucan recognition and control of fungal infection.

Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto M, Gordon S, Brown GD.

Nat Immunol. 2007 Jan;8(1):31-8. Epub 2006 Dec 10.

12.

Envisioning future strategies for vaccination against tuberculosis.

Kaufmann SH.

Nat Rev Immunol. 2006 Sep;6(9):699-704. doi: 10.1038/nri1920. Epub 2006 Aug 18. Review.

PMID:
16917508
13.

Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.

Gross O, Gewies A, Finger K, Schäfer M, Sparwasser T, Peschel C, Förster I, Ruland J.

Nature. 2006 Aug 10;442(7103):651-6. Epub 2006 Jul 12.

PMID:
16862125
14.
15.

A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC.

J Exp Med. 2006 Jul 10;203(7):1685-91. Epub 2006 Jul 3.

16.

Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31.

Agger EM, Rosenkrands I, Olsen AW, Hatch G, Williams A, Kritsch C, Lingnau K, von Gabain A, Andersen CS, Korsholm KS, Andersen P.

Vaccine. 2006 Jun 29;24(26):5452-60. Epub 2006 Apr 17.

PMID:
16675077
17.

Macrophage scavenger receptor down-regulates mycobacterial cord factor-induced proinflammatory cytokine production by alveolar and hepatic macrophages.

Ozeki Y, Tsutsui H, Kawada N, Suzuki H, Kataoka M, Kodama T, Yano I, Kaneda K, Kobayashi K.

Microb Pathog. 2006 Apr;40(4):171-6. Epub 2006 Mar 6.

PMID:
16517114
18.

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.

Davidsen J, Rosenkrands I, Christensen D, Vangala A, Kirby D, Perrie Y, Agger EM, Andersen P.

Biochim Biophys Acta. 2005 Dec 10;1718(1-2):22-31. Epub 2005 Nov 14.

19.

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.

Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT.

Nat Immunol. 2005 Nov;6(11):1123-32. Epub 2005 Oct 2.

20.

The success and failure of BCG - implications for a novel tuberculosis vaccine.

Andersen P, Doherty TM.

Nat Rev Microbiol. 2005 Aug;3(8):656-62. Review.

PMID:
16012514

Supplemental Content

Support Center